CD4 and metabolic dysfunction-associated steatotic liver disease: Ma et al. reported that the disruption of mitochondrial function by dysregulation of lipid metabolism in non-alcoholic fatty liver disease, leads to selective loss of intrahepatic CD4+ T cells and accelerating hepatocarcinogenesis [31].